TAYSHA GENE THERAPIES INC (TSHA)

US8776191061 - Common Stock

2.39  +0.76 (+46.63%)

After market: 2.4499 +0.06 (+2.51%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to TSHA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.54. This target is 173.53% above the current price.
TSHA was analyzed by 17 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about TSHA.
In the previous month the buy percentage consensus was at a similar level.
TSHA was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 2.395.057.146.548.40 - 111.30% 198.74% 173.53% 251.46%
Up and Down Grades
Date Firm Action Rating
2024-11-12 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-11-12 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-11-12 Needham Reiterate Buy -> Buy
2024-08-14 Canaccord Genuity Maintains Buy -> Buy
2024-08-13 Chardan Capital Maintains Buy -> Buy
2024-08-12 Needham Maintains Buy -> Buy
2024-07-26 Needham Reiterate Buy -> Buy
2024-07-23 Needham Reiterate Buy -> Buy
2024-07-01 Piper Sandler Maintains Overweight -> Overweight
2024-06-27 BMO Capital Initiate Outperform
2024-06-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-06-20 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-06-19 Needham Reiterate Buy -> Buy
2024-06-18 Chardan Capital Maintains Buy -> Buy
2024-06-17 Needham Reiterate Buy -> Buy
2024-05-28 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-05-15 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-05-15 Needham Reiterate Buy -> Buy
2024-05-02 Needham Reiterate Buy -> Buy
2024-04-30 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-19 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-18 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-11 Needham Reiterate Buy -> Buy
2024-04-09 Piper Sandler Initiate Overweight
2024-03-21 Chardan Capital Maintains Buy -> Buy
2024-03-21 Canaccord Genuity Reiterate Buy -> Buy
2024-03-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-03-20 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-03-20 Needham Maintains Buy -> Buy
2024-02-29 Needham Reiterate Buy -> Buy